Monthly Archives: May 2025

MHRA Class 4 Medicines Defect Notification: Chloramphenicol 1% w/w Eye Ointment, Blumont Pharma Limited Drug alert number: EL(25)A/20 Date issued: 08 May 2025 Blumont Pharma Limited has informed the MHRA of an error with the European Article Number (EAN) barcode on the cartons of the batch of Chloramphenicol 1% w/w Eye Ointment (POM version only) in [...]

The post MHRA Class 4 Medicines Defect Notification: Chloramphenicol 1% w/w Eye Ointment, Blumont Pharma Limited appeared first on Community Pharmacy England.

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued guidance regarding the risk of psychological side effects while taking Kaftrio▼ (Ivacaftor, tezacaftor, elexacaftor). Psychological side effects such as anxiety, low mood, sleep disturbance, poor concentration, and forgetfulness have been infrequently reported in people with cystic fibrosis treated with Kaftrio. Healthcare professionals should advise patients [...]

The post MHRA Drug Safety Update: Kaftrio▼ (Ivacaftor, tezacaftor, elexacaftor) risk of psychological side effects appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Lidocaine (Xylocaine®) 10mg/dose spray sugar free. MSN/2025/028 Tier 2 – medium impact Date of issue: 7th May 2025 Lidocaine (Xylocaine®) 10mg/dose spray sugar free is out of stock from mid-May until late June 2025. Lidocaine 5% / Phenylephrine 0.5% nasal spray [...]

The post Medicine Supply Notification: Lidocaine (Xylocaine® ) 10mg/dose spray sugar free appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Buprenorphine (Reletrans®) 5micrograms/hour and 15micrograms/hour transdermal patches. MSN/2025/030 Tier 2 – medium impact Date of issue: 7th May 2025 Buprenorphine (Reletrans®) 5micrograms/hour and 15micrograms/hour transdermal patches are out of stock until early July 2025. Alternative brands of buprenorphine matrix patches (Bunov®, [...]

The post Medicine Supply Notification: Buprenorphine (Reletrans® ) 5micrograms/hour and 15micrograms/hour transdermal patches appeared first on Community Pharmacy England.

Pharmacy owners are now able to make a claim for an Aspiration payment for the Pharmacy Quality Scheme (PQS) 2025/26 on the NHS Business Services Authority’s Manage Your Service (MYS) portal. The Aspiration payment is optional; if pharmacy owners do not want to claim it, it will not impact on the pharmacy owner’s ability to [...]

The post PQS: The Aspiration payment window is now open appeared first on Community Pharmacy England.